These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 7768270)

  • 21. In vitro study of immunoreactive corticotropin-releasing factor release from the rat hypothalamus.
    Suda T; Yajima F; Tomori N; Demura H; Shizume K
    Life Sci; 1985 Oct; 37(16):1499-505. PubMed ID: 2995748
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Influence of nitric oxide synthase inhibitors on the ACTH and cytokine responses to peripheral immune signals.
    Kim CK; Rivier C
    J Neuroendocrinol; 1998 May; 10(5):353-62. PubMed ID: 9663649
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of nitric oxide in control of prolactin release by the adenohypophysis.
    Duvilanski BH; Zambruno C; Seilicovich A; Pisera D; Lasaga M; Diaz MC; Belova N; Rettori V; McCann SM
    Proc Natl Acad Sci U S A; 1995 Jan; 92(1):170-4. PubMed ID: 7529411
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rat hypothalamic corticotropin-releasing hormone secretion in vitro is stimulated by interleukin-1 in an eicosanoid-dependent manner.
    Bernardini R; Calogero AE; Mauceri G; Chrousos GP
    Life Sci; 1990; 47(17):1601-7. PubMed ID: 2123510
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of intravenous administration of interleukin-1-beta on the release of prostaglandin E2, corticotropin-releasing factor, and arginine vasopressin in several hypothalamic areas of freely moving rats: estimation by push-pull perfusion.
    Watanobe H; Takebe K
    Neuroendocrinology; 1994 Jul; 60(1):8-15. PubMed ID: 8090286
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nitric oxide mediates central activation of sympathetic outflow induced by interleukin-1 beta in rats.
    Murakami Y; Yokotani K; Okuma Y; Osumi Y
    Eur J Pharmacol; 1996 Dec; 317(1):61-6. PubMed ID: 8982720
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Stimulating effect of HIV-1 coat protein gp120 on corticotropin-releasing hormone and arginine vasopressin in the rat hypothalamus: involvement of nitric oxide.
    Costa A; Nappi RE; Polatti F; Poma A; Grossman AB; Nappi G
    Exp Neurol; 2000 Dec; 166(2):376-84. PubMed ID: 11085902
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Valproic acid inhibits corticotropin-releasing factor synthesis and release from the rat hypothalamus in vitro: evidence for the involvement of GABAergic neurotransmission.
    Tringali G; Aubry JM; Moscianese K; Zamori C; Vairano M; Preziosi P; Navarra P; Pozzoli G
    J Psychiatry Neurosci; 2004 Nov; 29(6):459-66. PubMed ID: 15644987
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of L-NAME, a specific nitric oxide synthase inhibitor, on corticotropin-releasing hormone-elicited ACTH and corticosterone secretion.
    Bugajski J; Borycz J; Gadek-Michalska A; Głód R
    J Physiol Pharmacol; 1998 Dec; 49(4):607-16. PubMed ID: 10069701
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nitric oxide synthase inhibitors inhibit interleukin-1 beta-induced depression of vascular smooth muscle.
    French JF; Lambert LE; Dage RC
    J Pharmacol Exp Ther; 1991 Oct; 259(1):260-4. PubMed ID: 1717680
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Blockade of nitric oxide formation augments adrenocorticotropin released by blood-borne interleukin-1 beta: role of vasopressin, prostaglandins, and alpha 1-adrenergic receptors.
    Rivier C
    Endocrinology; 1995 Aug; 136(8):3597-603. PubMed ID: 7628398
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interleukin-1 (IL-1) stimulates the release of corticotropin-releasing factor (CRF) from superfused rat hypothalamo-neurohypophyseal complexes (HNC) independently of the histaminergic mechanism.
    Ohgo S; Nakatsuru K; Ishikawa E; Matsukura S
    Brain Res; 1991 Sep; 558(2):217-23. PubMed ID: 1782543
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intravenous interleukin-1-beta-induced inhibition of gastric emptying: involvement of central corticotrophin-releasing factor and prostaglandin pathways in rats.
    Sütö G; Király A; Plourde V; Taché Y
    Digestion; 1996; 57(2):135-40. PubMed ID: 8786002
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Regulation of nitric oxide-like activity by prostanoids in smooth muscle of the canine saphenous vein.
    Illiano S; Marsault R; Descombes JJ; Verbeuren T; Vanhoutte PM
    Br J Pharmacol; 1996 Jan; 117(2):360-4. PubMed ID: 8789391
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nitric oxide mediates norepinephrine-induced prostaglandin E2 release from the hypothalamus.
    Rettori V; Gimeno M; Lyson K; McCann SM
    Proc Natl Acad Sci U S A; 1992 Dec; 89(23):11543-6. PubMed ID: 1280829
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nitric oxide mediates the interleukin-1beta- and nicotine-induced hypothalamic-pituitary-adrenocortical response during social stress.
    Gadek-Michalska A; Bugajski J
    J Physiol Pharmacol; 2005 Sep; 56(3):491-503. PubMed ID: 16204770
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interleukin-1 directly stimulates the release of corticotrophin releasing factor from rat hypothalamus.
    Tsagarakis S; Gillies G; Rees LH; Besser M; Grossman A
    Neuroendocrinology; 1989 Jan; 49(1):98-101. PubMed ID: 2785660
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Stimulation by interleukin-1 (IL-1) of the release of rat corticotropin-releasing factor (CRF), which is independent of the cholinergic mechanism, from superfused rat hypothalamo-neurohypophysial complexes.
    Ohgo S; Nakatsuru K; Oki Y; Ishikawa E; Matsukura S
    Brain Res; 1991 Jun; 550(2):213-9. PubMed ID: 1679371
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cytokine-induced change in hypothalamic norepinephrine turnover: involvement of corticotropin-releasing hormone and prostaglandins.
    Terao A; Oikawa M; Saito M
    Brain Res; 1993 Sep; 622(1-2):257-61. PubMed ID: 8242363
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of nitric oxide in the control of luteinizing hormone-releasing hormone release in vivo and in vitro.
    Rettori V; Belova N; Dees WL; Nyberg CL; Gimeno M; McCann SM
    Proc Natl Acad Sci U S A; 1993 Nov; 90(21):10130-4. PubMed ID: 7694282
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.